These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


333 related items for PubMed ID: 9371603

  • 21. Murine coronavirus evolution in vivo: functional compensation of a detrimental amino acid substitution in the receptor binding domain of the spike glycoprotein.
    Navas-Martin S, Hingley ST, Weiss SR.
    J Virol; 2005 Jun; 79(12):7629-40. PubMed ID: 15919915
    [Abstract] [Full Text] [Related]

  • 22. The spike protein of murine coronavirus mouse hepatitis virus strain A59 is not cleaved in primary glial cells and primary hepatocytes.
    Hingley ST, Leparc-Goffart I, Weiss SR.
    J Virol; 1998 Feb; 72(2):1606-9. PubMed ID: 9445064
    [Abstract] [Full Text] [Related]

  • 23. The N-terminal domain of the murine coronavirus spike glycoprotein determines the CEACAM1 receptor specificity of the virus strain.
    Tsai JC, Zelus BD, Holmes KV, Weiss SR.
    J Virol; 2003 Jan; 77(2):841-50. PubMed ID: 12502800
    [Abstract] [Full Text] [Related]

  • 24. Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier.
    Kuo L, Godeke GJ, Raamsman MJ, Masters PS, Rottier PJ.
    J Virol; 2000 Feb; 74(3):1393-406. PubMed ID: 10627550
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The virulence of mouse hepatitis virus strain A59 is not dependent on efficient spike protein cleavage and cell-to-cell fusion.
    Hingley ST, Leparc-Goffart I, Seo SH, Tsai JC, Weiss SR.
    J Neurovirol; 2002 Oct; 8(5):400-10. PubMed ID: 12402166
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Purified, soluble recombinant mouse hepatitis virus receptor, Bgp1(b), and Bgp2 murine coronavirus receptors differ in mouse hepatitis virus binding and neutralizing activities.
    Zelus BD, Wessner DR, Williams RK, Pensiero MN, Phibbs FT, deSouza M, Dveksler GS, Holmes KV.
    J Virol; 1998 Sep; 72(9):7237-44. PubMed ID: 9696818
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Sequence analysis of the S gene of recombinant MHV-2/A59 coronaviruses reveals three candidate mutations associated with demyelination and hepatitis.
    Das Sarma J, Fu L, Hingley ST, Lai MM, Lavi E.
    J Neurovirol; 2001 Oct; 7(5):432-6. PubMed ID: 11582515
    [Abstract] [Full Text] [Related]

  • 32. Immunogenic peptide comprising a mouse hepatitis virus A59 B-cell epitope and an influenza virus T-cell epitope protects against lethal infection.
    Koolen MJ, Borst MA, Horzinek MC, Spaan WJ.
    J Virol; 1990 Dec; 64(12):6270-3. PubMed ID: 1700835
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Mouse hepatitis virus neurovirulence: evidence of a linkage between S glycoprotein expression and immunopathology.
    Rempel JD, Murray SJ, Meisner J, Buchmeier MJ.
    Virology; 2004 Jan 05; 318(1):45-54. PubMed ID: 14972534
    [Abstract] [Full Text] [Related]

  • 35. Purification of the 110-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV)-A59 from mouse liver and identification of a nonfunctional, homologous protein in MHV-resistant SJL/J mice.
    Williams RK, Jiang GS, Snyder SW, Frana MF, Holmes KV.
    J Virol; 1990 Aug 05; 64(8):3817-23. PubMed ID: 2164599
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.